Innophos Holdings (IPHS) Tops Q4 EPS by 4c

Innophos Holdings (NASDAQ: IPHS) reported Q4 EPS of $0.52, $0.04 better than the analyst estimate of $0.48. Revenue for the quarter came in at $168 million versus the consensus estimate of $153.36 million.

"2016 was a meaningful and transformative year for Innophos as we strengthened the foundation of our business, delivered bottom line improvement and laid the groundwork for strategic growth," said Kim Ann Mink, Ph.D., Chief Executive Officer. "By remaining laser focused on reducing costs across the organization, we lowered input costs by a total of $22 million annually, $12 million of which was through our Operational Excellence initiatives and the balance from market conditions. Our 2016 financial results are a true testament to the performance driven culture we are cultivating at Innophos. Throughout the organization our teams are embracing the transformation that is underway, delivering results and displaying a commitment to excellence, transparency and accountability."

"The fourth quarter was highlighted by bottom line growth and tremendous cash generation. We grew margins even as we faced ongoing market headwinds. Our focus on efficient working capital resulted in meaningful free cash flow performance in the quarter that was more than triple the prior year. We also refinanced our credit facility with lower interest rates and an expanded capacity to support our Strategic Growth pillar."

"As we move forward into 2017, although we expect market headwinds to continue, we are well positioned to deliver enhanced shareholder value," Dr. Mink continued. \"Our focus will be on executing additional bottom line savings as we move to the next phase of Operational Excellence initiatives, which will standardize processes and reduce costs while improving how we operate. In addition, our Commercial Excellence blueprint that better aligns our sales organization with market opportunities and key customers will be fully implemented. Further, we plan to drive sustainable growth through acquisitions in attractive, high-growth, functional food, health and nutrition market segments. We are actively seeking opportunities to expand our capabilities and build upon our experience in providing value-added and innovative technology-based solutions to these markets."

Dr. Mink concluded, "I am confident that in the year ahead, we will leverage the momentum of our progress in 2016 by taking the appropriate, decisive next steps to further strengthen our competitive position, improve profitability and solidify Innophos' future growth prospects.

For earnings history and earnings-related data on Innophos Holdings (IPHS) click here.

You May Also Be Interested In

• Tesla to launch Cybercab in Austin this month - report
• BofA Securities Reiterates Buy Rating on Micron Technology (MU); Sees $230+ in EPS by FY30
• XP Inc. (XP) Tops Q2 EPS by 8c